27
Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the Pacific Western University of Health Sciences Charles Drew University 4 th Annual Drug Abuse Research Symposium September 26,2008

Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Embed Size (px)

Citation preview

Page 1: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Zebrafish: An emerging model in drug abuse research

Kevin S. Jones, Ph.D.Assistant. Professor PharmacologyThe College of Osteopathic Medicine of the PacificWestern University of Health Sciences

Charles Drew University 4th Annual Drug Abuse Research Symposium September 26,2008

Page 2: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

What is a “zebrafish”?

Page 3: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

The zebrafish, Danio rerio, is:

• Tropical, fresh water fish native of India.

•Member of the teleost class (bony fish).

•Well established model for vertebrate development.

•Readily accessible to transgenesis.

Page 4: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Zebrafish have 3 developmental stages

~30 hpf (hours post fertilization)

1 mm

Embryonic

> 3 months

Adult

5 dpf

1 mm

Larval

Page 5: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Zebrafish as a model organism

Advantages Disadvantages1. Small size

2. High fecundity

3. Sequenced genome

4. Optical transparency

5. External Development

6. Genetic manipulation

7. Automated analysis

Evolutionarily distant from humans

Limited behavioral repertoire

Page 6: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Larval zebrafish (10dpf)

96 well plateU.S. Penny

Page 7: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

How can zebrafish be used to study drug abuse?

Page 8: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Recreational “Illy” (PCP) Smoker

Page 9: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

pcp

PCP (phencyclidine) blocks NMDA receptors

PCP

PCP

Page 10: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

kd < 5 nM

MK-801

MK-801 is a potent analogue of PCP

Page 11: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Psychostimulants cause movement disorders

Actions of psychostimulantsDrug-treated

HUMANDrug-treated

RodentsHallucinations YES ???

Delusions YES ???

Thought Disorder YES YES

Movement Disorders YES YES

Page 12: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Zebrafish have NMDA receptors

• zNMDAR is ~90 % IDENTICAL to human NMDAR

•Expressed as early as 24 hpf

Developmental Dynamics 2005 234: 756-766

Page 13: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Objective:

Characterize the behavioral effects of NMDA receptor blockade in zebrafish

Page 14: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

• Individual zebrafish larvae are placed into single wells of a multi well plate

• Multi-plate illuminated from below with a 15w lightbox

• Larvae given 5 minutes to acclimate

• Subsequent activity recorded for 5 minutes on digital camera

Data Acquisition

Methods

Page 15: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

MethodsData Analysis

• Video recordings analyzed off-line with particle tracking software

Page 16: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Vehicle-treated MK-801-treated

Prototypical Data

Page 17: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Dose Response of MK-801-induced locomotion

EC50 ~ 10.3 uM

Page 18: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Locomotor kinetics

t (h)

Spe

ed

(mm

/sec

)

Page 19: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Developmental Sensitivity

Page 20: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

The antipsychotic, ziprasidone,attenuate the locomotor effects of MK-801

Page 21: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Ziprasidone targets several receptors

Target Receptor D2 D3 5HT2A 5HT2C 5HT1A 5HT1D α1

Ki 4.8 7.2 0.4 1.3 3.4 2 10

Page 22: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Dopamine antagonists do not disrupt MK-801-indcued locomotion

Page 23: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

MPTP pre-treatment diminishes locomotor effects of MK-801

Δ S

PE

ED

(mm

/sec

)

VEH 500 uM MPTP 1 mM MPTP

Page 24: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Summary• Zebrafish retain the most reliable symptom of

NMDA blockade… increased locomotion.

• Antipsychotic meds block behavioral effects in zebrafish.

• Zebrafish may prove useful for elucidating importantmolecular pathways of drugs of abuse

Page 25: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Future Directions

• Elucidate molecular mechanism(s).• Examine developmental sensitivity.• Probe for behavioral sensitization.• Molecular neurotoxicology.

Page 26: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the

Acknowledgments

Mr. John Chen (Pomona College)

Ms. Roshni Patel (Pomona College)

Biology Dept Pomona College

Pomona College—Dean’s office

Page 27: Zebrafish: An emerging model in drug abuse research Kevin S. Jones, Ph.D. Assistant. Professor Pharmacology The College of Osteopathic Medicine of the